Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Our genetic differences as means of treatment

Jacques Fellay receives the National Latsis Prize 2012
The medical researcher Jacques Fellay is studying the human genome in search of genetic variations that influence how the body reacts to a virus and to the drugs fighting it. He is to be awarded the National Latsis Prize 2012 for his research.

Jacques Fellay is a "bridge builder" and an advocate of translational research, a discipline that allows the results of basic research to be transferred to medical practice. Always on the borderline between laboratory and hospital, he is of the opinion that, in order to discover medically useful solutions, an exchange between the two worlds is needed.

Jacques Fellay applies this thinking in his own research, which is conducted at the intersection of genomics and infectious diseases and for which he receives the National Latsis Prize 2012. The information stored in our genes can be of great value for developing new treatments.

Different responses to drugs
At the beginning of the millennium, the treatment of HIV patients - persons who were infected with the virus that causes AIDS - still involved serious, undesired side-effects. Jacques Fellay, then a doctoral student of Amalio Telenti in Lausanne, discovered the existence of genetic variations that influence the individual's response to antiretroviral drugs: some patients have a higher concentration of drugs in the blood than others, which in turn increases the risk of a toxic reaction. Knowledge of their genetic profile now makes it easier to predict harmful effects and adjust the treatment accordingly.

During a four-year stay at Duke University in the United States, Jacques Fellay became interested in the genetic material of people who are carriers of the hepatitis C virus. He discovered that the genetic make-up of the patient played a significant role in the success of antiviral treatments, which are only effective in 50 percent of the cases. Today, these genetic predictors of the response to drugs are taken into account by doctors when they choose a treatment.

Fighting viral diseases
At the same time, Fellay kept on studying the HIV virus. He identified three genes that enable certain patient populations to exercise better immune control over the disease. This could be a crucial step towards the development of a vaccine.

Since 2011, as the holder of an SNSF professorship and head of his own lab at the Faculty of Life Sciences at EPF Lausanne, Jacques Fellay has kept on searching for features of the human genome that make it possible to counter viral diseases. Together with his team, he is studying mutations that occur in HIV when fought by the immune system and investigating the genetic variations of infected persons that might be the cause of this.

Bridges of hope
Jacques Fellay is also attempting to understand the different reactions of children to seasonal flu and the respiratory syncytial virus. Why do some children only have fever for a few days, while others need to be admitted to the intensive care unit? Jacques Fellay is convinced of the potential that genomics holds for the future of medicine and continues to build bridges of hope between science and medical practice.

Worth 100,000 Swiss francs, the National Latsis Prize is one of the most prestigious scientific awards in Switzerland. Each year, the Swiss National Science Foundation presents the prize on behalf of the Latsis Foundation to researchers of up to 40 years of age in recognition of their special contribution to science in Switzerland.

The prize will be awarded on 10 January 2013 at the Rathaus in Berne.

Prizes of the Latsis Foundation
The Latsis Foundation was established by the Greek family Latsis in Geneva in 1975. The National Latsis Prize is awarded by the Swiss National Science Foundation on behalf of the Latsis Foundation. In addition, there are four university Latsis prizes worth 25,000 Swiss francs each, which are awarded by the University of Geneva, the University of St. Gallen, ETH Zurich and EPF Lausanne.

Prof. Jacques Fellay
Global Health Institute
Faculty of Life Sciences
EPF Lausanne
CH-1015 Lausanne
Tel.: +41 (0)21 693 18 49

Abteilung Kommunikation | idw
Further information:

More articles from Awards Funding:

nachricht Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)

nachricht ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>